52
Views
24
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Evaluation of quality of life in relation to anxiety and depression in primary Sjögren’s syndrome

, , , &
Pages 588-597 | Received 11 Mar 2010, Accepted 28 May 2010, Published online: 02 Jan 2014

References

  • Tzioufas AG, Mitsias ID, Mouthsopoulos HM. Sjogren's syn-drome. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology, vol. II. 4th ed. Mosby: Elsevier; 2008. p. 1341–52.
  • Fox RI. Sjogren's syndrome. Lancet. 2005;366:321–31.
  • Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. Sjogren's syn-drome: why autoimmune epithelitis? Oral Dis. 2006;12:523–32.
  • Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006;35:379–83.
  • Thomas E, Hay EM, Hajeer A, Silman J. Sjogren's syndrome: a community-based study of prevalence and impact. Br J Rheu-matol. 1998;37:1069–76.
  • Boonen A, Rasker JJ, Stucki G. The international classification for functioning, disability and health. A challenge and a need for rheumatology. Clin Rheumatol. 2007;26:1803–8.
  • Szabo S. The World Health Organisation Quality of life (WHOQOL) assesment instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Philadelphia: Lipincot-Raven; 1996. p. 355–62.
  • Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. J Am Med Assoc. 1989;262:907–13.
  • Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford). 2009;48(9):1077–82.
  • Bjerrum K, Prause JU. Primary Sjogren's syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283–8.
  • The WHOQOL Group. Development of the WHOQOL: rationale and current status. Int J. Ment Health. 1994;23(3):24–56.
  • The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psy-chol Med. 1998;28:551–8.
  • Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.
  • Bjelland I, Dahl AA, Haung TT, Neckelman D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.
  • Fidaner H, Elbi H, Fidaner C, Eser SY, Eser E, Goker E. Measuring quality of life WHOQOL-100 and WHOQOL-bref. J Psychiatr Psychol Psychopharmacol. 1999;7:23–41.
  • Koorigit H, Aydemir O, Fisek G, Olmez N, Memis A. Turkish validity and reliability of short-form 36. Drug Treat. 1999;12: 102–6.
  • Diindar P, Fidaner C, Fidaner H, Oral A, Eser S, Atman UC, et al. Comparing the Turkish versions of WHOQOL-BREF and SF-36. Convergent validity of WHOQOL-BREF and SF-36. Hippokra-tia. 2002;6\(Suppl 1):37–43.
  • Aydemir O,.Giivenir T, Kiiey L, Kiiltiir S. Hastane Anksiyete ye Depresyon Okegi Tiirkçe Formunun geçerlilik ye gfivenilirligi. Tiirk Psikiyatri Derg. 1997;8:187–280.
  • Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new ques-tionnaire tool. Rheumatology. 2004;43:758–64.
  • McMillan AS, Leung KC, Leung WK, Wong MC, Lau CS, Mok TM. Impact of Sjogren's syndrome on oral health-related quality of life in southern Chinese. J Oral Rehabil. 2004;31(7):653–9.
  • Rostron J, Rogers S, Longman L, Kaney S, Field EA. Health-related quality of life in patients with primary Sjogren's syn-drome and xerostomia: a comparative study. Gerodontology. 2002;19(1):53–9.
  • Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brod-scholl J, et al. Primary Sjogren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;27(7):46.
  • Baturone R, Soto M, Marquez M, Macias I, Montes de Oca M, Medina F, et al. Health-related quality of life in patients with primary Sjogren's syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol. 2009;2:1–4.
  • Belenguer R, Ramos-Casals M, Brito-Zerón P, del Pino J, Sentis J, Aguiló S, et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjogren's syndrome. Clin Exp Rheumatol. 2005;23(3): 351–6.
  • Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L. Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000;29(1): 20–8.
  • Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 2008;139(3):291–9.
  • Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythe-matosus (SLE), SLE and Sjogren's syndrome (SS), and primary SS. J Rheumatol. 1998;25:63–8.
  • Tensing EK, Solovieva SA, Tervahartiala T, Nordstrom DC, Laine M, Niissalo S, et al. Fatigue and health profile in sicca syndrome of Sjogren's and non-Sjogren's syndrome origin. Clin Exp Rheumatol. 2001;19:313–6.
  • Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caumont C, et al. Quality of life and psychological status in patients with primary Sjogren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum (Arthritis Care Res). 2006;55:451–7.
  • Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjogren's syndrome are at increased risk from clinical depression. Gerodontology. 2004;21:141–5.
  • ValtYsdóttir ST, Gudbjomsson B, Hällgren R, Hetta J. Psycho-logical well-being in patients with primary Sjogren's syndrome. Clin Exp Rheumatol. 2000;18(5):597–600.
  • ValtYsdóttir ST, Gudbjörnsson B, Lindqvist U, Hällgren R, Hetta J. Anxiety and depression in patients with primary Sjogren's syndrome. J Rheumatol. 2000;27(1):165–9.
  • Kuyken W, Orley J, Hudelson P, Sartorius N. Quality of life assessment across cultures. Int J. Ment Health. 1994;23:5–27.
  • Huang PC, Fang CT, Chang YY, Chen MY, Wang JD. Com-parison of WHOQOL-BREF and SF-36 in patients with HIV infection. Qual Life Res. 2005;14: 141–50.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.
  • Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardieri C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160–72.
  • Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270–80.
  • Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A com-mentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res. 2003;12:599–607.
  • Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62(1):115–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.